1例慢性阻塞性肺疾病急性加重期患者的药学监护  

Pharmaceutical care on a patient with acute exacerbation of chronic obstructive pulmonary disease

作　　者：申音[1,2] 魏文树[1] 宋洪涛[1] 

机构地区：[1]南京军区福州总医院药学科,福建福州350025 [2]沈阳药科大学药学院,辽宁沈阳110016

出　　处：《中国药物应用与监测》2012年第3期147-149,共3页Chinese Journal of Drug Application and Monitoring

摘　　要：1例75岁男性患者,因反复咳嗽、咳痰10余年,胸闷、气喘半天入院治疗,初步诊断为慢性阻塞性肺疾病急性加重期,入院后给予头孢哌酮钠舒巴坦钠、左氧氟沙星、氨溴索等治疗,临床药师对治疗方案进行分析,结合患者的疾病特点、用药选择、药物不良反应等情况,对患者使用抗感染、平喘等药物提出用药建议。治疗15 d患者病情稳定出院。One 75-year-old male patient with cough and sputum for 10 years, dyspnea and asthma was admired to hospital, and acute exacerbation of chronic obstructive pulmonary disease was diagnosed. Cefoperazone sodium and sulbactam sodium, levofloxacin and ambroxol were given. According to the disease characteristics of the patient, selection of medication and adverse drug reaction, clinical pharmacists made recommendations on the rational use of anti-infection drugs and anti-asthma drugs. After 15 days, the patient got recovery.

关 键 词：慢性阻塞性肺疾病 急性加重期 药学监护 

分 类 号：R563.9[医药卫生—呼吸系统]